BioMarin Pharmaceuticals was formed in 1997 as through an investment from Glyko Biomedical Ltd. BioMarin Pharmaceuticals utilizes their unique enzyme technology to advance research and development in the unmet areas of serious diseases and medical conditions. BioMarin Pharmaceuticals currently offers two products, Naglazyme and Aldurazyme, that treat the symptoms associated with specific stages of mucopolysaccharidosis. They have also partnered with companies such as Genzyme Corporation and Serono, providing the development end of the partnership.
Naglazyme is an enzyme replacement therapy launched BioMarin Pharmaceuticals in 2005. Naglazyme has been approved by the FDA for the treatment of MPS VI. Naglazyme is administered through injection form.
Naglazyme Premium/Co-Payment Assistance Program, a patient assistance program provided by BioMarin Pharmaceuticals, offers co-payment assistance Naglazyme for up to one year to those who are eligible for the program. Eligibility is based off of the following requirements:
- You must meet undisclosed income and insurance guidelines.
The medication must be sent to the physicians office.
Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call BioMarin Pharmaceuticals program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.
- If you have any questions please call the BioMarin Pharmaceuticals program directly.
- Fill out as much of the information on the enrollment form as possible. The more information you have pre-filled the easier the progrm is to enroll in.
- Write down the refill dates for your program and set a reminder here on PatientAssistance.com so that you don't run out of medication.
- Do not write messy on your forms as this will delay any response.
- Call and write thank you notes to AAI Pharma Inc. program. Without their help millions of people will be without medication.